Table 2 Comparison of baseline characteristics between the control and T2D groups
Baseline Characteristics | Control | T2D | p |
|---|---|---|---|
Men/women (n) | 61/53 | 78/61 | 0.989 |
Age (years) | 65 ± 9 | 65 ± 8 | 0.267 |
Body weight (kg) | 74.9 ± 14.6 | 86.2 ± 14.4 | < 0.001* |
Height (cm) | 163 ± 0.1 | 164 ± 0.09 | 0.298 |
BMI (kg/m2) | 28 ± 4.8 | 31.8 ± 4.6 | < 0.001* |
Waist circumference (cm) | 97 ± 10.7 | 105.9 ± 10.8 | < 0.001* |
FPG (mg/dL) | 91 (84–99) | 143 (107–173) | < 0.001* |
HbA1c (%) | 5.6 (5.4–5.8) | 7.6 (6.9–8.6) | < 0.001* |
TG (mg/dL) | 103 (78–144) | 139 (99–197) | < 0.001* |
HDL-c (mg/dL) | 54 ± 12 | 46 ± 11 | < 0.001* |
LDL-c (mg/dL) | 116 ± 32 | 93 ± 40 | < 0.001* |
eGFR (mL/min/1.73 m2) | 86.3 (73.5–94) | 87 (71.1–97.5) | 0.568 |
Calcium (mg/dL) | 9.7 (9.5–10.1) | 9.7 (9.5–9.9) | 0.553 |
Phosphorous (mg/dL) | 3.2 (2.9–3.5) | 3.3 (2.9–3.6) | 0.169 |
25(OH)D (ng/mL) | 25.6 ± 8.5 | 20.7 ± 8.5 | < 0.001* |
P1NP (ng/mL) | 43.8 ± 21 | 37.2 ± 15 | 0.002* |
ALP (µg/L) | 12.6 (10.3–16.9) | 16.6 (13.3–21.4) | < 0.001* |
iPTH (pg/mL) | 52 (40.1–69.3) | 46.8 (31.25-61) | 0.007* |
OC (ng/mL) | 21.7 ± 17.4 | 10.8 ± 5.6 | < 0.001* |
Periostin (pmol/L) | 1208.8 (972–1452) | 1147 (936–1546) | 0.975 |
Sclerostin (pmol/L) | 32.6 (24.82–43.14) | 39.02 (28.20-49.47) | 0.003* |